Advertisement

Topics

Infliximab Introduction Has Not Cut IBD-Related Hospitalizations

08:00 EDT 14 Jun 2019 | Drugs.com

FRIDAY, June 14, 2019 -- Marketplace introduction of infliximab has not resulted in reductions in the population rates of inflammatory bowel disease (IBD)-related hospitalizations or intestinal resections or colectomies, according to a study...

Original Article: Infliximab Introduction Has Not Cut IBD-Related Hospitalizations

NEXT ARTICLE

More From BioPortfolio on "Infliximab Introduction Has Not Cut IBD-Related Hospitalizations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...